6-Bromo-2,3-dihydro-pyrano[2,3-b]pyridin-4-one

Catalog No.: 
ACRNYW573
CAS No.: 
1196155-15-3
Molecular Formula: 
C8H6BrNO2
Molecular Weight: 
228.04
6-Bromo-2,3-dihydro-pyrano[2,3-b]pyridin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$306.00InquiryInquiry
100mg98%$448.00InquiryInquiry
250mg98%$631.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-2,3-dihydro-pyrano[2,3-b]pyridin-4-one
IUPAC Name6-bromo-2,3-dihydro-4H-pyrano[2,3-b]pyridin-4-one
MDL No.MFCD13189697
Molecular FormulaC8H6BrNO2
Molecular Weight228.04
SMILESO=C1CCOC2=NC=C(Br)C=C21
InChI KeyWBLGHRGVFAGBAR-UHFFFAOYSA-N
Synonym6-bromo-2H-pyrano[2,3-b]pyridin-4(3H)-one;6-Bromo-2,3-dihydro-pyrano[2,3-b]pyridin-4-one;6-Bromo-2,3-dihydro-4H-pyrano[2,3-b]pyridin-4-one;6-bromo-2H-pyrano[2,3-b]pyridin-4(3H)-one(WX142544);4H-Pyrano[2,3-b]pyridin-4-one, 6-bromo-2,3-dihydro-
CAS No.1196155-15-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRNYW573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNYW573 route product structure diagram
    ACRNYW5731196155-15-3
Inquiry

2. ACRNYW573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNYW573 route product structure diagram
    ACRNYW5731196155-15-3
Inquiry

3. ACRNYW573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNYW573 route product structure diagram
    ACRNYW5731196155-15-3
Inquiry

Comments (0)